[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368004-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368004-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-dual-role-of-mir-184-in-cancer-a-systematic-review-of-context-dependent-regulation","The dual role of miR-184 in cancer - a systematic review of context-dependent regulation","","MicroRNA-184 (miR-184) regulates gene expression by binding to target messenger RNAs, promoting degradation and shaping key cellular processes. Evidence in human cancers is complex: multiple studies describe tumour-suppressive functions, such as reduced proliferation, migration, and metastasis, while contradictory findings suggest tumour-promoting activity in specific contexts. This systematic review assessed whether miR-184 acts as a universal anticancer agent across human cancers. Searches in PubMed and SCOPUS identified 123 records, with 55 meeting inclusion criteria.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-dual-role-of-mir-184-in-cancer-a-systematic-review-of-context-dependent-regulation/368004/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-dual-role-of-mir-184-in-cancer-a-systematic-review-of-context-dependent-regulation/368004.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does miR-184 do at the molecular level?","Question",{"text":63,"@type":64},"miR-184 regulates gene expression by binding to target messenger RNAs, promoting their degradation and influencing key cellular processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is miR-184’s role in cancer described as complex?",{"text":68,"@type":64},"Studies report both tumour-suppressive effects and tumour-promoting activity depending on cellular context, indicating it is not uniformly anticancer.",{"name":70,"@type":61,"acceptedAnswer":71},"How was the systematic review conducted and what were the main inclusion results?",{"text":72,"@type":64},"A comprehensive search of PubMed and SCOPUS identified 123 records, and 55 studies met the inclusion criteria.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368004,1790548810,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Molecular Biology Reports (2026) 53:188  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1033-025-11314-4  \nREVIEW  \nThe dual role of miR-184 in cancer: a systematic review of contextdependent regulation  \nBrandon Duff1,2 · Rasha Swadi1,3  \nReceived: 13 October 2025 / Accepted: 24 November 2025 © The Author(s) 2025  \nAbstract  \nMicroRNA-184 (miR-184) regulates gene expression by binding to target messenger RNAs, promoting their degradation, and influencing key cellular processes. Its role in human cancers is complex: while several studies report tumour-suppressive effects, including inhibition of proliferation, migration, and metastasis, contradictory evidence indicates that miR-184 may act as a tumour promoter in certain contexts. This systematic review aimed to clarify whether miR-184 functions as a universal anticancer agent across human cancers. A comprehensive search of PubMed and SCOPUS identified 123 records, of which 55 studies met inclusion criteria. Analysis revealed that miR-184 predominantly acts as a tumour suppressor in cancers such as prostate and breast, whereas in liver and bone cancers, it exhibits tumour-promoting activity. Certain cancer types, including skin and pancreatic cancers, showed inconsistent or context-dependent effects. Key molecular targetsand pathways influenced by miR-184, including c-MYC, caspases, and apoptotic signalling, were highlighted. Overall, these findings demonstrate that the function of miR-184 in cancer is context-dependent, shaped by tissue type, molecular environment, and cellular signalling networks.  \nKeywords MicroRNA-184 (miR-184) · Context-dependent regulation · Therapeutic biomarker · LncRNA–ceRNA network · Tumour suppressor  \nAbbreviations  \nAC  \nART  \nBC  \nBCCBcl-2  \nCCND1  \nCDC25A  \nceRNA  \nCML  \nAdenocarcinoma Artesunate  \nBreast cancer Basal cell carcinoma B cell lymphoma 2  \nCyclin D1  \nCell division cycle 25A Competitive endogenous RNA Chronic myeloid leukaemia  \nBrandon Duff and Rasha Swadi Both author contributed equally to this work.  \n􀀍 Rasha Swadi[r.r.swadi@ljmu.ac.uk](r.r.swadi@ljmu.ac.uk)  \n1 School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK  \n2 School of Biological Sciences, University of Reading, Reading, UK  \n3 Institute for Health Research, Liverpool John Moores University, Liverpool, UK  \nCNSL  \nCRC  \nDTX1  \nE-cadherin  \nEGFR  \nEMT  \nEPAS1  \nFENDRR  \nFIH  \nFIH-1  \nGC  \nGHPA  \nHCCHIF-1α  \nhnRNPA2B1  \nhnSCC  \nHuR  \nCentral nervous system lymphoma Colorectal carcinoma  \nDeltex-1  \nEpithelial cadherin  \nEpidermal growth factor receptor Endothelial-to-mesenchymal transition Endothelial PAS domain protein 1  \nFoetal-lethal non-coding developmental regulatory RNA  \nFactor-inhibiting hypoxia-inducible factor  \nFactor inhibiting hypoxia-inducible factor 1  \nGastric cancer  \nGrowth hormone-secreting pituitary adenoma  \nHepatocellular carcinoma  \nHypoxia-inducible factor 1 alpha; HK, hyperkeratosis  \nHeterogeneous nuclear ribonucleoprotein A2/B1  \nHead and neck squamous cell carcinoma Human antigen R  \n1 3  \nHPV  \nIGF-1RiASPP  \nIPF  \nJNK1  \nLAPClncRNA  \nMALT  \nMC  \nMEG3 miRNA  \nmiR-21  \nmiR-184  \nmRNA  \nmTOR  \nmTORC1  \nMTUS1  \nN-cadherin Notch2 NPC  \nNSCLC  \noeSCC  \norSCC  \nPC  \nPDAC  \nPD-L1  \nPI3K  \nPRCCRAGRF1  \nRb  \nRCC  \nRC  \nSCC  \nSCLC  \nSC  \nSA  \nSNHG11  \nSND1  \nSOX7 TGF-β1 TNFAIP2  \nTNFAIP8  \nTNBC  \nUCA1  \nHuman papilloma virus  \nInsulin-like growth factor receptor 1 Inhibitory member of apoptosis-stimulating protein of p53  \nIdiopathic pulmonary fibrosis C-JUN N-terminal kinase 1  \nLocally advanced prostate cancer Long non-coding RNA  \nMucosa-associated lymphoid tissue lymphoma  \nMedullary carcinoma  \nMaternally expressed gene 3  \nMicroRNA  \nMicroRNA-21  \nMicroRNA-184  \nMessenger RNA  \nMechanistic target of rapamycin  \nMechanistic target of rapamycin complex 1  \nMicrotubule-associated tumour suppressor 1  \nNeural cadherin Notch receptor 2  \nNasopharyngeal carcinoma  \nNon-small cell lung cancer Oesophagea","cbCaiqRoi0XlnhOP","https://ap.wps.com/l/cbCaiqRoi0XlnhOP","pdf",2443816,25,"English","# Abstract\n# Abbreviations\n## MicroRNA and cancer-related abbreviations\n# Introduction","[{\"question\":\"What does miR-184 do at the molecular level?\",\"answer\":\"miR-184 regulates gene expression by binding to target messenger RNAs, promoting their degradation and influencing key cellular processes.\"},{\"question\":\"Why is miR-184’s role in cancer described as complex?\",\"answer\":\"Studies report both tumour-suppressive effects and tumour-promoting activity depending on cellular context, indicating it is not uniformly anticancer.\"},{\"question\":\"How was the systematic review conducted and what were the main inclusion results?\",\"answer\":\"A comprehensive search of PubMed and SCOPUS identified 123 records, and 55 studies met the inclusion criteria.\"}]","The dual role of miR-184 in cancer - a systematic review of context-dependent regulation | PDF",1790174291,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56536e38414960f4f3f902fb6f83b707.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d47a84ad91daf2897f5f59dda3454c4.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21cdffdde53053b869e9e340c7de2d1c.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e654c02848b2cd6659cc6d3f2c2197ad.webp",980,1301]